News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
105last 24h
3127last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Investor's Business Daily60d agoneutral
IPO Stock LB Pharma Has Tripled In Under A Year. Is It A Takeover Target?24/7 Wall St.80d agoneutral
Why Bristol Myers, Johnson & Johnson and More Are Watching Seaport After IPOInsider Monkey89d agobullish
AstraZeneca PLC (AZN) vs. Bristol-Myers Squibb Company (BMY): Wall Street Doesn’t Buy This Merger TalkInvestorsHub95d agobearish
AZN rebounds after report dismisses AstraZeneca-Bristol Myers merger speculationThe Wall Street Journal95d agoneutral
Novo Nordisk CEO Remains Open to Bolt-On Acquisitions, But Rules out Transformative DealsSimply Wall St.96d agoneutral
AstraZeneca (LSE:AZN) Is In Merger Talks With Bristol Myers For $400 BillionBarrons.com96d agoneutral
AstraZeneca-Bristol Myers: The Floodgates for Biotech Mergers Are OpenInvesting.com97d agoneutral
Bristol-Myers Squibb and AstraZeneca said to discuss megamerger - can it happen?Investopedia97d agobullish
Bristol Myers Squibb Stock Jumps on Reported Merger Talks With AstraZenecaBarrons.com97d agobearish
Bristol Myers Squibb Stock Soars on Report of $400 Billion Merger Talks With AstraZeneca